(Q61933779)
Statements
EMMA-1 (English)
0 references
Phase II Study of Cetuximab for the Refractory or Relapsed Multiple Myeloma EMMA-1(Erbitux for Multiple Myeloma) (English)
0 references
August 2006
0 references
June 2012
0 references
13
0 references
18 year
0 references